These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 28284054

  • 1. Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability.
    Kaithwas V, Dora CP, Kushwah V, Jain S.
    Colloids Surf B Biointerfaces; 2017 Jun 01; 154():10-20. PubMed ID: 28284054
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs.
    Chai R, Gao H, Ma Z, Guo M, Fu Q, Liu H, He Z.
    Curr Drug Deliv; 2019 Jun 01; 16(6):500-510. PubMed ID: 31244438
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension.
    Pandya NT, Jani P, Vanza J, Tandel H.
    Colloids Surf B Biointerfaces; 2018 May 01; 165():37-44. PubMed ID: 29453084
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fabrication of Nanosuspension Directly Loaded Fast-Dissolving Films for Enhanced Oral Bioavailability of Olmesartan Medoxomil: In Vitro Characterization and Pharmacokinetic Evaluation in Healthy Human Volunteers.
    Alsofany JM, Hamza MY, Abdelbary AA.
    AAPS PharmSciTech; 2018 Jul 01; 19(5):2118-2132. PubMed ID: 29700766
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability Enhancement of Olmesartan Medoxomil Using Hot-Melt Extrusion: In-Silico, In-Vitro, and In-Vivo Evaluation.
    Jadhav P, Gokarna V, Deshpande V, Vavia P.
    AAPS PharmSciTech; 2020 Sep 04; 21(7):254. PubMed ID: 32888102
    [Abstract] [Full Text] [Related]

  • 13. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N, Veerabrahma K.
    Drug Deliv; 2016 Sep 04; 23(2):395-404. PubMed ID: 24865287
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.
    Albash R, El-Nabarawi MA, Refai H, Abdelbary AA.
    Int J Nanomedicine; 2019 Sep 04; 14():6555-6574. PubMed ID: 31616143
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
    Neupane YR, Srivastava M, Ahmad N, Kumar N, Bhatnagar A, Kohli K.
    Int J Pharm; 2014 Dec 30; 477(1-2):601-12. PubMed ID: 25445972
    [Abstract] [Full Text] [Related]

  • 18. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
    Sangsen Y, Wiwattanawongsa K, Likhitwitayawuid K, Sritularak B, Wiwattanapatapee R.
    Colloids Surf B Biointerfaces; 2015 Jul 01; 131():182-90. PubMed ID: 25988282
    [Abstract] [Full Text] [Related]

  • 19. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, Pan YS, Tang X.
    Int J Pharm; 2010 Jul 15; 394(1-2):179-85. PubMed ID: 20471464
    [Abstract] [Full Text] [Related]

  • 20. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
    Paudel A, Ameeduzzafar, Imam SS, Fazil M, Khan S, Hafeez A, Ahmad FJ, Ali A.
    Curr Drug Deliv; 2017 Jul 15; 14(7):1005-1015. PubMed ID: 28034361
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.